img

Global Molecular Residual Disease Detection Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Molecular Residual Disease Detection Market Insights, Forecast to 2034

Molecular residual lesions often refer to minimal residual lesions, which refer to a small number of cancer cells that remain in the body after cancer treatment (cancer cells that do not respond to treatment or are drug-resistant).
Market Analysis and InsightsGlobal Molecular Residual Disease Detection Market
Global Molecular Residual Disease Detection market is expected to reach to US$ 5405 million in 2023, with a positive growth of %, compared with US$ 4680 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Molecular Residual Disease Detection industry is evaluated to reach US$ 12900 million in 2033. The CAGR will be 15.6% during 2023 to 2033.
Globally, Molecular Residual Disease Detection key companies include Adaptive, Guardant Health, Invitae, Cergentis B.V, LexentBio, Natera, BGI, Zhiben Medical and Burning Rock Medicine, etc. Adaptive, Guardant Health, Invitae are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of Molecular Residual Disease Detection were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole Molecular Residual Disease Detection market and estimated to attract more attentions from industry insiders and investors.
Molecular Residual Disease Detection can be divided into Tumor-informed Assays and Tumor-agnostic Assays, etc. Tumor-informed Assays is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
Molecular Residual Disease Detection is widely used in various fields, such as Prognosis, Adjuvant Treatment Decision-Making, Surveillance for Postoperative Recurrence and Other, etc. Prognosis provides greatest supports to the Molecular Residual Disease Detection industry development. In 2022, global % revenue of Molecular Residual Disease Detection went into Prognosis filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Molecular Residual Disease Detection market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Molecular Residual Disease Detection market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Adaptive
Guardant Health
Invitae
Cergentis B.V
LexentBio
Natera
BGI
Zhiben Medical
Burning Rock Medicine
Huidu Medical
Zhenhe Technology
ExactSciences
Segment by Type
Tumor-informed Assays
Tumor-agnostic Assays

Segment by Application


Prognosis
Adjuvant Treatment Decision-Making
Surveillance for Postoperative Recurrence
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Molecular Residual Disease Detection introduction, etc. Molecular Residual Disease Detection Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Molecular Residual Disease Detection
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Residual Disease Detection Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Tumor-informed Assays
1.2.3 Tumor-agnostic Assays
1.3 Market by Application
1.3.1 Global Molecular Residual Disease Detection Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Prognosis
1.3.3 Adjuvant Treatment Decision-Making
1.3.4 Surveillance for Postoperative Recurrence
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Molecular Residual Disease Detection Market Perspective (2018-2033)
2.2 Global Molecular Residual Disease Detection Growth Trends by Region
2.2.1 Molecular Residual Disease Detection Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Molecular Residual Disease Detection Historic Market Size by Region (2018-2023)
2.2.3 Molecular Residual Disease Detection Forecasted Market Size by Region (2024-2033)
2.3 Molecular Residual Disease Detection Market Dynamics
2.3.1 Molecular Residual Disease Detection Industry Trends
2.3.2 Molecular Residual Disease Detection Market Drivers
2.3.3 Molecular Residual Disease Detection Market Challenges
2.3.4 Molecular Residual Disease Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Molecular Residual Disease Detection by Players
3.1.1 Global Molecular Residual Disease Detection Revenue by Players (2018-2023)
3.1.2 Global Molecular Residual Disease Detection Revenue Market Share by Players (2018-2023)
3.2 Global Molecular Residual Disease Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Molecular Residual Disease Detection, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Molecular Residual Disease Detection Market Concentration Ratio
3.4.1 Global Molecular Residual Disease Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Residual Disease Detection Revenue in 2022
3.5 Global Key Players of Molecular Residual Disease Detection Head office and Area Served
3.6 Global Key Players of Molecular Residual Disease Detection, Product and Application
3.7 Global Key Players of Molecular Residual Disease Detection, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Residual Disease Detection Breakdown Data by Type
4.1 Global Molecular Residual Disease Detection Historic Market Size by Type (2018-2023)
4.2 Global Molecular Residual Disease Detection Forecasted Market Size by Type (2024-2033)
5 Molecular Residual Disease Detection Breakdown Data by Application
5.1 Global Molecular Residual Disease Detection Historic Market Size by Application (2018-2023)
5.2 Global Molecular Residual Disease Detection Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Molecular Residual Disease Detection Market Size (2018-2033)
6.2 North America Molecular Residual Disease Detection Market Size by Type
6.2.1 North America Molecular Residual Disease Detection Market Size by Type (2018-2023)
6.2.2 North America Molecular Residual Disease Detection Market Size by Type (2024-2033)
6.2.3 North America Molecular Residual Disease Detection Market Share by Type (2018-2033)
6.3 North America Molecular Residual Disease Detection Market Size by Application
6.3.1 North America Molecular Residual Disease Detection Market Size by Application (2018-2023)
6.3.2 North America Molecular Residual Disease Detection Market Size by Application (2024-2033)
6.3.3 North America Molecular Residual Disease Detection Market Share by Application (2018-2033)
6.4 North America Molecular Residual Disease Detection Market Size by Country
6.4.1 North America Molecular Residual Disease Detection Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Molecular Residual Disease Detection Market Size by Country (2018-2023)
6.4.3 North America Molecular Residual Disease Detection Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Molecular Residual Disease Detection Market Size (2018-2033)
7.2 Europe Molecular Residual Disease Detection Market Size by Type
7.2.1 Europe Molecular Residual Disease Detection Market Size by Type (2018-2023)
7.2.2 Europe Molecular Residual Disease Detection Market Size by Type (2024-2033)
7.2.3 Europe Molecular Residual Disease Detection Market Share by Type (2018-2033)
7.3 Europe Molecular Residual Disease Detection Market Size by Application
7.3.1 Europe Molecular Residual Disease Detection Market Size by Application (2018-2023)
7.3.2 Europe Molecular Residual Disease Detection Market Size by Application (2024-2033)
7.3.3 Europe Molecular Residual Disease Detection Market Share by Application (2018-2033)
7.4 Europe Molecular Residual Disease Detection Market Size by Country
7.4.1 Europe Molecular Residual Disease Detection Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Molecular Residual Disease Detection Market Size by Country (2018-2023)
7.4.3 Europe Molecular Residual Disease Detection Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Molecular Residual Disease Detection Market Size (2018-2033)
8.2 China Molecular Residual Disease Detection Market Size by Type
8.2.1 China Molecular Residual Disease Detection Market Size by Type (2018-2023)
8.2.2 China Molecular Residual Disease Detection Market Size by Type (2024-2033)
8.2.3 China Molecular Residual Disease Detection Market Share by Type (2018-2033)
8.3 China Molecular Residual Disease Detection Market Size by Application
8.3.1 China Molecular Residual Disease Detection Market Size by Application (2018-2023)
8.3.2 China Molecular Residual Disease Detection Market Size by Application (2024-2033)
8.3.3 China Molecular Residual Disease Detection Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Molecular Residual Disease Detection Market Size (2018-2033)
9.2 Asia Molecular Residual Disease Detection Market Size by Type
9.2.1 Asia Molecular Residual Disease Detection Market Size by Type (2018-2023)
9.2.2 Asia Molecular Residual Disease Detection Market Size by Type (2024-2033)
9.2.3 Asia Molecular Residual Disease Detection Market Share by Type (2018-2033)
9.3 Asia Molecular Residual Disease Detection Market Size by Application
9.3.1 Asia Molecular Residual Disease Detection Market Size by Application (2018-2023)
9.3.2 Asia Molecular Residual Disease Detection Market Size by Application (2024-2033)
9.3.3 Asia Molecular Residual Disease Detection Market Share by Application (2018-2033)
9.4 Asia Molecular Residual Disease Detection Market Size by Region
9.4.1 Asia Molecular Residual Disease Detection Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Molecular Residual Disease Detection Market Size by Region (2018-2023)
9.4.3 Asia Molecular Residual Disease Detection Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Type
10.2.1 Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Application
10.3.1 Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Country
10.4.1 Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Adaptive
11.1.1 Adaptive Company Details
11.1.2 Adaptive Business Overview
11.1.3 Adaptive Molecular Residual Disease Detection Introduction
11.1.4 Adaptive Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.1.5 Adaptive Recent Developments
11.2 Guardant Health
11.2.1 Guardant Health Company Details
11.2.2 Guardant Health Business Overview
11.2.3 Guardant Health Molecular Residual Disease Detection Introduction
11.2.4 Guardant Health Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.2.5 Guardant Health Recent Developments
11.3 Invitae
11.3.1 Invitae Company Details
11.3.2 Invitae Business Overview
11.3.3 Invitae Molecular Residual Disease Detection Introduction
11.3.4 Invitae Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.3.5 Invitae Recent Developments
11.4 Cergentis B.V
11.4.1 Cergentis B.V Company Details
11.4.2 Cergentis B.V Business Overview
11.4.3 Cergentis B.V Molecular Residual Disease Detection Introduction
11.4.4 Cergentis B.V Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.4.5 Cergentis B.V Recent Developments
11.5 LexentBio
11.5.1 LexentBio Company Details
11.5.2 LexentBio Business Overview
11.5.3 LexentBio Molecular Residual Disease Detection Introduction
11.5.4 LexentBio Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.5.5 LexentBio Recent Developments
11.6 Natera
11.6.1 Natera Company Details
11.6.2 Natera Business Overview
11.6.3 Natera Molecular Residual Disease Detection Introduction
11.6.4 Natera Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.6.5 Natera Recent Developments
11.7 BGI
11.7.1 BGI Company Details
11.7.2 BGI Business Overview
11.7.3 BGI Molecular Residual Disease Detection Introduction
11.7.4 BGI Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.7.5 BGI Recent Developments
11.8 Zhiben Medical
11.8.1 Zhiben Medical Company Details
11.8.2 Zhiben Medical Business Overview
11.8.3 Zhiben Medical Molecular Residual Disease Detection Introduction
11.8.4 Zhiben Medical Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.8.5 Zhiben Medical Recent Developments
11.9 Burning Rock Medicine
11.9.1 Burning Rock Medicine Company Details
11.9.2 Burning Rock Medicine Business Overview
11.9.3 Burning Rock Medicine Molecular Residual Disease Detection Introduction
11.9.4 Burning Rock Medicine Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.9.5 Burning Rock Medicine Recent Developments
11.10 Huidu Medical
11.10.1 Huidu Medical Company Details
11.10.2 Huidu Medical Business Overview
11.10.3 Huidu Medical Molecular Residual Disease Detection Introduction
11.10.4 Huidu Medical Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.10.5 Huidu Medical Recent Developments
11.11 Zhenhe Technology
11.11.1 Zhenhe Technology Company Details
11.11.2 Zhenhe Technology Business Overview
11.11.3 Zhenhe Technology Molecular Residual Disease Detection Introduction
11.11.4 Zhenhe Technology Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.11.5 Zhenhe Technology Recent Developments
11.12 ExactSciences
11.12.1 ExactSciences Company Details
11.12.2 ExactSciences Business Overview
11.12.3 ExactSciences Molecular Residual Disease Detection Introduction
11.12.4 ExactSciences Revenue in Molecular Residual Disease Detection Business (2018-2023)
11.12.5 ExactSciences Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Molecular Residual Disease Detection Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Tumor-informed Assays
Table 3. Key Players of Tumor-agnostic Assays
Table 4. Global Molecular Residual Disease Detection Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global Molecular Residual Disease Detection Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Molecular Residual Disease Detection Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Molecular Residual Disease Detection Market Share by Region (2018-2023)
Table 8. Global Molecular Residual Disease Detection Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Molecular Residual Disease Detection Market Share by Region (2024-2033)
Table 10. Molecular Residual Disease Detection Market Trends
Table 11. Molecular Residual Disease Detection Market Drivers
Table 12. Molecular Residual Disease Detection Market Challenges
Table 13. Molecular Residual Disease Detection Market Restraints
Table 14. Global Molecular Residual Disease Detection Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Molecular Residual Disease Detection Revenue Share by Players (2018-2023)
Table 16. Global Top Molecular Residual Disease Detection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Residual Disease Detection as of 2022)
Table 17. Global Molecular Residual Disease Detection Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Molecular Residual Disease Detection Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Molecular Residual Disease Detection, Headquarters and Area Served
Table 20. Global Key Players of Molecular Residual Disease Detection, Product and Application
Table 21. Global Key Players of Molecular Residual Disease Detection, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Molecular Residual Disease Detection Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Molecular Residual Disease Detection Revenue Market Share by Type (2018-2023)
Table 25. Global Molecular Residual Disease Detection Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Molecular Residual Disease Detection Revenue Market Share by Type (2024-2033)
Table 27. Global Molecular Residual Disease Detection Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Molecular Residual Disease Detection Revenue Share by Application (2018-2023)
Table 29. Global Molecular Residual Disease Detection Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Molecular Residual Disease Detection Revenue Share by Application (2024-2033)
Table 31. North America Molecular Residual Disease Detection Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Molecular Residual Disease Detection Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America Molecular Residual Disease Detection Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Molecular Residual Disease Detection Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America Molecular Residual Disease Detection Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Molecular Residual Disease Detection Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Molecular Residual Disease Detection Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Molecular Residual Disease Detection Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Molecular Residual Disease Detection Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe Molecular Residual Disease Detection Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Molecular Residual Disease Detection Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe Molecular Residual Disease Detection Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe Molecular Residual Disease Detection Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Molecular Residual Disease Detection Market Size by Country (2024-2033) & (US$ Million)
Table 45. China Molecular Residual Disease Detection Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Molecular Residual Disease Detection Market Size by Type (2024-2033) & (US$ Million)
Table 47. China Molecular Residual Disease Detection Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Molecular Residual Disease Detection Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia Molecular Residual Disease Detection Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Molecular Residual Disease Detection Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia Molecular Residual Disease Detection Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Molecular Residual Disease Detection Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia Molecular Residual Disease Detection Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia Molecular Residual Disease Detection Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Molecular Residual Disease Detection Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Molecular Residual Disease Detection Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size by Country (2024-2033) & (US$ Million)
Table 63. Adaptive Company Details
Table 64. Adaptive Business Overview
Table 65. Adaptive Molecular Residual Disease Detection Product
Table 66. Adaptive Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 67. Adaptive Recent Developments
Table 68. Guardant Health Company Details
Table 69. Guardant Health Business Overview
Table 70. Guardant Health Molecular Residual Disease Detection Product
Table 71. Guardant Health Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 72. Guardant Health Recent Developments
Table 73. Invitae Company Details
Table 74. Invitae Business Overview
Table 75. Invitae Molecular Residual Disease Detection Product
Table 76. Invitae Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 77. Invitae Recent Developments
Table 78. Cergentis B.V Company Details
Table 79. Cergentis B.V Business Overview
Table 80. Cergentis B.V Molecular Residual Disease Detection Product
Table 81. Cergentis B.V Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 82. Cergentis B.V Recent Developments
Table 83. LexentBio Company Details
Table 84. LexentBio Business Overview
Table 85. LexentBio Molecular Residual Disease Detection Product
Table 86. LexentBio Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 87. LexentBio Recent Developments
Table 88. Natera Company Details
Table 89. Natera Business Overview
Table 90. Natera Molecular Residual Disease Detection Product
Table 91. Natera Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 92. Natera Recent Developments
Table 93. BGI Company Details
Table 94. BGI Business Overview
Table 95. BGI Molecular Residual Disease Detection Product
Table 96. BGI Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 97. BGI Recent Developments
Table 98. Zhiben Medical Company Details
Table 99. Zhiben Medical Business Overview
Table 100. Zhiben Medical Molecular Residual Disease Detection Product
Table 101. Zhiben Medical Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 102. Zhiben Medical Recent Developments
Table 103. Burning Rock Medicine Company Details
Table 104. Burning Rock Medicine Business Overview
Table 105. Burning Rock Medicine Molecular Residual Disease Detection Product
Table 106. Burning Rock Medicine Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 107. Burning Rock Medicine Recent Developments
Table 108. Huidu Medical Company Details
Table 109. Huidu Medical Business Overview
Table 110. Huidu Medical Molecular Residual Disease Detection Product
Table 111. Huidu Medical Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 112. Huidu Medical Recent Developments
Table 113. Zhenhe Technology Company Details
Table 114. Zhenhe Technology Business Overview
Table 115. Zhenhe Technology Molecular Residual Disease Detection Product
Table 116. Zhenhe Technology Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 117. Zhenhe Technology Recent Developments
Table 118. ExactSciences Company Details
Table 119. ExactSciences Business Overview
Table 120. ExactSciences Molecular Residual Disease Detection Product
Table 121. ExactSciences Revenue in Molecular Residual Disease Detection Business (2018-2023) & (US$ Million)
Table 122. ExactSciences Recent Developments
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Residual Disease Detection Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Molecular Residual Disease Detection Market Share by Type: 2022 VS 2033
Figure 3. Tumor-informed Assays Features
Figure 4. Tumor-agnostic Assays Features
Figure 5. Global Molecular Residual Disease Detection Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global Molecular Residual Disease Detection Market Share by Application: 2022 VS 2033
Figure 7. Prognosis Case Studies
Figure 8. Adjuvant Treatment Decision-Making Case Studies
Figure 9. Surveillance for Postoperative Recurrence Case Studies
Figure 10. Other Case Studies
Figure 11. Molecular Residual Disease Detection Report Years Considered
Figure 12. Global Molecular Residual Disease Detection Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Molecular Residual Disease Detection Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Molecular Residual Disease Detection Market Share by Region: 2022 VS 2033
Figure 15. Global Molecular Residual Disease Detection Market Share by Players in 2022
Figure 16. Global Top Molecular Residual Disease Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Residual Disease Detection as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Molecular Residual Disease Detection Revenue in 2022
Figure 18. North America Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Molecular Residual Disease Detection Market Share by Type (2018-2033)
Figure 20. North America Molecular Residual Disease Detection Market Share by Application (2018-2033)
Figure 21. North America Molecular Residual Disease Detection Market Share by Country (2018-2033)
Figure 22. United States Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Molecular Residual Disease Detection Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Molecular Residual Disease Detection Market Share by Type (2018-2033)
Figure 26. Europe Molecular Residual Disease Detection Market Share by Application (2018-2033)
Figure 27. Europe Molecular Residual Disease Detection Market Share by Country (2018-2033)
Figure 28. Germany Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Molecular Residual Disease Detection Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Molecular Residual Disease Detection Market Share by Type (2018-2033)
Figure 36. China Molecular Residual Disease Detection Market Share by Application (2018-2033)
Figure 37. Asia Molecular Residual Disease Detection Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Molecular Residual Disease Detection Market Share by Type (2018-2033)
Figure 39. Asia Molecular Residual Disease Detection Market Share by Application (2018-2033)
Figure 40. Asia Molecular Residual Disease Detection Market Share by Region (2018-2033)
Figure 41. Japan Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Molecular Residual Disease Detection Market Share by Country (2018-2033)
Figure 51. Brazil Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Molecular Residual Disease Detection Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Adaptive Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 58. Guardant Health Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 59. Invitae Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 60. Cergentis B.V Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 61. LexentBio Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 62. Natera Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 63. BGI Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 64. Zhiben Medical Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 65. Burning Rock Medicine Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 66. Huidu Medical Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 67. Zhenhe Technology Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 68. ExactSciences Revenue Growth Rate in Molecular Residual Disease Detection Business (2018-2023)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries